ESC 365 - The ARAMIS trial - Allopurinol in patients with Refractory Angina to iMprove Ischemic Symptoms

Back

ESC2025 Premium Access

The ARAMIS trial - Allopurinol in patients with Refractory Angina to iMprove Ischemic Symptoms

Session: Inflammation in chronic coronary syndromes

Topic: Pharmacotherapy

Speaker: Doctor R. Azevedo (Sao Paulo, BR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Renato Azevedo

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

0 follower

6 more presentations in this session

Influenza vaccination and risk of cardiovascular events: a prespecified instrumental variable analysis of NUDGE-FLU-CHRONIC

Speaker: Doctor D. Modin (Copenhagen, DK)

Assessing the cardiovascular toll of chronic inflammatory arthropathies: a case-control study on coronary artery disease severity

Speaker: Mr A. Castrillo Capilla (Madrid, ES)

Awareness and perceptions on the role of systemic inflammation in atherosclerotic cardiovascular disease and chronic kidney disease: a national study among cardiologists and nephrologists in China

Speaker: Associate Professor X. Liu (Beijing, CN)

Impact of nutritional status on MACCE in CAD patients: the mediating role of inflammation

Speaker: Doctor Q. Sun (Beijing, CN)

Long-term impact of residual inflammatory risk in acute myocardial infarction patients with low LDL Cholesterol levels

Speaker: Professor C. Kim (Seoul, KR)

Access the full session

Inflammation in chronic coronary syndromes

Speakers: Doctor R. Azevedo, Doctor D. Modin, Mr A. Castrillo Capilla, Associate Professor X. Liu, Doctor Q. Sun...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources